NEURONOPATHIC LYSOSOMAL STORAGE DISEASES: CLINICAL AND PATHOLOGIC FINDINGS

被引:12
|
作者
Prada, Carlos E. [1 ,2 ]
Grabowski, Gregory A. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Dept Pediat, Cincinnati, OH 45229 USA
[2] Cardiovasc Fdn Colombia, Ctr Genom Med & Metab, Floridablanca, Colombia
关键词
lysosomal storage diseases; neuronopathic disease; autophagy; inflammation; cell death; pathogenesis; NEURONAL CEROID-LIPOFUSCINOSES; ACID MALTASE DEFICIENCY; TAY-SACHS-DISEASE; GLOBOID-CELL LEUKODYSTROPHY; GAUCHER-DISEASE; SANDHOFF-DISEASE; KRABBE-DISEASE; PARKINSON-DISEASE; MOUSE MODEL; NEUROAXONAL DYSTROPHY;
D O I
10.1002/ddrr.1116
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The lysosomal-autophagocytic system diseases (LASDs) affect multiple body systems including the central nervous system (CNS). The progressive CNS pathology has its onset at different ages, leading to neurodegeneration and early death. Methods: Literature review provided insight into the current clinical neurological findings, phenotypic spectrum, and pathogenic mechanisms of LASDs with primary neurological involvement. Conclusions: CNS signs and symptoms are variable and related to the disease-specific underlying pathogenesis. LAS dysfunction leads to diverse global cellular consequences in the CNS ranging from specific axonal and dendritic abnormalities to neuronal death. Pathogenic mechanisms for disease progression vary from impaired autophagy, massive storage, regional involvement, to end-stage inflammation. Some of these features are also found in adult neurodegenerative disorders, for example, Parkinson's and Alzheimer's diseases. Lack of effective therapies is a significant unmet medical need. (C) 2013 Wiley Periodicals, Inc.
引用
收藏
页码:226 / 246
页数:21
相关论文
共 50 条
  • [31] Neuroinflammatory paradigms in lysosomal storage diseases
    Bosch, Megan E.
    Kielian, Tammy
    FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [32] Role of induced pluripotent stem cells in lysosomal storage diseases
    Kido, Jun
    Nakamura, Kimitoshi
    Era, Takumi
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2020, 108
  • [33] Neuronopathic Gaucher disease: Beyond lysosomal dysfunction
    Arevalo, Nohela B.
    Lamaizon, Cristian M.
    Cavieres, Viviana A.
    Burgos, Patricia V.
    alvarez, Alejandra R.
    Yanez, Maria J.
    Zanlungo, Silvana
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [34] Magnetic resonance imaging findings of central nervous system in lysosomal storage diseases: A pictorial review
    Fagan, Nathan
    Alexander, Allen
    Irani, Neville
    Saade, Charbel
    Naffaa, Lena
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2017, 61 (03) : 344 - 352
  • [35] Clinical Studies in Lysosomal Storage Diseases: Past, Present And Future
    Boudes, Pot F.
    PEDIATRIC ENDOCRINOLOGY REVIEWS PER, 2013, 11 : 68 - 76
  • [36] Lysosomal Leukodystrophies Lysosomal Storage Diseases Associated With White Matter Abnormalities
    Maegawa, Gustavo H. B.
    JOURNAL OF CHILD NEUROLOGY, 2019, 34 (06) : 339 - 358
  • [37] The cellular pathology of lysosomal diseases
    Cox, Timothy M.
    Cachon-Gonzalez, M. Begona
    JOURNAL OF PATHOLOGY, 2012, 226 (02) : 241 - 254
  • [38] Substrate reduction therapy for lysosomal storage diseases
    Cox, TM
    ACTA PAEDIATRICA, 2005, 94 : 69 - 75
  • [39] Unifying biology of neurodegeneration in lysosomal storage diseases
    Ludlaim, Anna M.
    Waddington, Simon N.
    Mckay, Tristan R.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (01)
  • [40] Lysosomal storage diseases as differential diagnosis of hepatosplenomegaly
    Vom Dahl, Stephan
    Mengel, Eugen
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2010, 24 (05) : 619 - 628